Key Takeaways:
- Pharma and life sciences organizations operate under a layered regulatory environment — FDA 21 CFR Part 11, GxP (GLP, GMP, GCP), HIPAA for patient data, and GDPR for international trials — requiring software that is validated, auditable, and compliant across multiple frameworks simultaneously.
- Taction builds clinical trial management systems, drug safety and pharmacovigilance platforms, regulatory submission tools, lab information management systems, and data analytics platforms for pharma and life sciences clients.
- Our development process follows IEC 62304 for software lifecycle management and 21 CFR Part 11 for electronic records and electronic signatures — with validation documentation built into every sprint, not produced retroactively.
Pharma-Specific Challenges We Solve
Clinical Trial Data Management
Clinical trials generate massive volumes of structured and unstructured data — patient demographics, lab results, adverse events, imaging, biomarker data, electronic patient-reported outcomes (ePRO), and site monitoring data. Managing this data across dozens of trial sites in multiple countries requires purpose-built software that enforces data integrity, supports real-time monitoring, and meets GCP (Good Clinical Practice) requirements.
How we solve it: Custom clinical trial management systems (CTMS) with electronic data capture (EDC), site management, randomization engines, real-time dashboards for trial monitors, and automated protocol deviation detection. Built with 21 CFR Part 11 compliance for electronic records and audit trails.
Drug Safety and Pharmacovigilance
Regulatory authorities (FDA, EMA) require pharmaceutical companies to collect, assess, and report adverse events throughout a drug’s lifecycle — from clinical trials through post-market surveillance. Safety signal detection, case processing, and regulatory submission timelines are strictly mandated.
How we solve it: Pharmacovigilance platforms with automated adverse event intake (from clinical trial sites, healthcare providers, patients, and published literature), MedDRA coding, case assessment workflows, signal detection algorithms, and automated regulatory report generation (ICSRs, PSURs, DSURs) for FDA and EMA submission.
Regulatory Submission Complexity
Drug approval requires assembling and submitting massive volumes of documentation — clinical study reports, CMC data, preclinical data, labeling, and post-market commitments — in formats mandated by each regulatory authority (eCTD for FDA, EU-CTD for EMA).
How we solve it: Regulatory information management systems with document lifecycle management, eCTD publishing tools, submission tracking, health authority correspondence management, and commitment tracking. Designed to support simultaneous global submissions across FDA, EMA, PMDA, and other authorities.
Lab Data Integration and LIMS
Pharmaceutical R&D and manufacturing laboratories generate data across instruments, assays, and processes that must be captured, validated, and reported in compliance with GLP (Good Laboratory Practice) and GMP (Good Manufacturing Practice) standards.
How we solve it: Laboratory Information Management System (LIMS) development and integration. Instrument data capture, sample tracking, test result management, specification compliance checking, certificate of analysis generation, and integration with ERP and quality management systems.
Real-World Evidence and Analytics
Pharma companies increasingly use real-world data (claims, EHR data, patient registries, wearable data) to support regulatory submissions, market access decisions, and post-market studies. Extracting actionable insights from heterogeneous real-world data sources requires sophisticated data engineering and analytics capabilities.
How we solve it: Healthcare data analytics platforms that ingest and normalize data from EHRs (via FHIR APIs), claims databases, patient registries, and wearable devices. NLP for unstructured clinical note extraction. ML models for outcome prediction and cohort identification. AI capabilities for signal detection and evidence synthesis.
Software We Build for Pharma
Clinical Trial Management Systems (CTMS)
Trial planning and protocol management, site selection and management, patient recruitment and enrollment tracking, randomization and blinding, electronic data capture (EDC), monitoring visit management, and protocol deviation tracking.
Pharmacovigilance Platforms
Adverse event intake and triage, MedDRA coding and case processing, causality assessment workflows, signal detection and management, regulatory report generation (ICSR, PSUR, DSUR), and health authority submission tracking.
Regulatory Information Management
Document lifecycle management, eCTD publishing and submission, health authority correspondence tracking, commitment and post-marketing requirement tracking, global submission planning, and labeling management.
Lab Information Management Systems (LIMS)
Sample lifecycle tracking, instrument integration and data capture, test result management with specification checking, stability study management, certificate of analysis generation, and GLP/GMP compliance documentation.
Patient Engagement for Clinical Trials
ePRO (electronic patient-reported outcomes) mobile applications, telemedicine for decentralized trial visits, medication adherence tracking, adverse event self-reporting, and trial participant communication platforms. Built with HIPAA compliance for patient data protection.
Real-World Evidence Platforms
Multi-source data ingestion (EHR, claims, registry, wearable), data normalization and quality management, cohort identification and analytics, outcome tracking and evidence generation, and regulatory-grade audit trails.
Compliance Framework for Pharma Software
Pharma software development requires compliance across multiple overlapping frameworks.
Regulation | What It Governs | How We Address It |
FDA 21 CFR Part 11 | Electronic records and signatures | Audit trails, e-signature validation, data integrity controls |
GCP (ICH E6) | Clinical trial conduct | EDC validation, protocol compliance, monitoring tools |
GLP | Lab data integrity | LIMS validation, instrument qualification, data audit trails |
GMP | Manufacturing data | Process controls, batch record integrity, deviation management |
HIPAA | Patient health information | Encryption, access controls, BAAs — full guide |
GDPR | EU patient data | Consent management, data subject rights, cross-border transfers |
IEC 62304 | Medical device software lifecycle | Lifecycle documentation, risk management, traceability |
ISO 13485 | Quality management for medical devices | QMS documentation, design controls, CAPA processes |
Our development process produces the validation documentation these frameworks require — not as a retroactive documentation exercise, but as an integrated part of every sprint. Requirements traceability, test protocols, validation reports, and change control documentation are built alongside the code.
For medical device software that may require FDA clearance (SaMD), we include regulatory pathway planning in the discovery phase.
Data Integration for Pharma
Pharma organizations need to connect clinical, lab, manufacturing, and commercial systems. Taction’s integration capabilities include EHR data extraction via FHIR APIs for real-world evidence, lab instrument integration for LIMS, EDC system connectivity for clinical trial data, ERP integration for manufacturing and supply chain, safety database integration for pharmacovigilance, and regulatory submission system connectivity. We use Mirth Connect for healthcare data transformation and routing where HL7/FHIR standards apply.
Discuss Your Pharma Project Building clinical trial software, a pharmacovigilance platform, or a real-world evidence system? Schedule a free consultation to discuss your regulatory and technical requirements. Discuss Your Project →
Related Resources:
Frequently Asked Questions
Yes. Our development process includes electronic record controls (audit trails, data integrity, access controls), electronic signature validation, and the documentation required for Part 11 compliance. Validation protocols and reports are produced as part of the development process, not retroactively.
Yes. Decentralized trial capabilities include ePRO mobile apps, telemedicine for remote visits, wearable data integration, e-consent, and remote monitoring dashboards — all built with HIPAA compliance and GCP awareness.
We build regulatory information management systems that support eCTD publishing for FDA, EU-CTD for EMA, and other regional formats. The systems manage the document lifecycle from authoring through submission and post-approval maintenance.
Multi-country data management requires GDPR compliance for EU data, country-specific privacy regulations, cross-border data transfer safeguards, and multi-language support. We design data architectures that accommodate these requirements from the start.